{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:16:37Z","timestamp":1790885797806,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jasc.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T01:53:57Z","timestamp":1590198837000},"page":"291-303","source":"Crossref","is-referenced-by-count":15,"title":["Moving forward\u2014the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories"],"prefix":"10.1016","volume":"9","author":[{"given":"Ritu","family":"Nayar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Chhieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Crothers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa M.","family":"Darragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane D.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-4323","authenticated-orcid":false,"given":"Carol","family":"Eisenhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goulart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana O.","family":"Tabbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2020.05.002_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3322\/caac.21139","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2020.05.002_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/LGT.0000000000000343","article-title":"Risks of CIN 2+, CIN 3+, and cancer by cytology and human papillomavirus status: the foundation of risk-based cervical screening guidelines","volume":"21","author":"Demarco","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/jnci\/djy192","article-title":"Role of screening history in clinical meaning and optimal management of positive cervical screening results","volume":"111","author":"Castle","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2020.05.002_bib4","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":"Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/LGT.0b013e3182854269","article-title":"Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/LGT.0000000000000382","article-title":"Low risk of cervical cancer\/precancer among most women under surveillance postcolposcopy","volume":"22","author":"Demarco","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib7","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.05.002_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000300","article-title":"Preparing for the next round of ASCCP-sponsored cervical screening and management guidelines","volume":"21","author":"Schiffman","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.currproblcancer.2018.06.007","article-title":"The next generation of cervical cancer screening programs: making the case for risk-based guidelines","volume":"42","author":"Perkins","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.jasc.2020.05.002_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/LGT.0000000000000378","article-title":"The next generation of cervical cancer screening: should guidelines focus on best practices for the future or current screening capacity?","volume":"22","author":"Castle","year":"2018","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/LGT.0000000000000531","article-title":"An introduction to the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Schiffman","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/LGT.0000000000000528","article-title":"2019 ASCCP risk-based management consensus guidelines: methods for risk estimation, recommended management, and validation","volume":"24","author":"Cheung","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/LGT.0000000000000524","article-title":"Incorporating stakeholder feedback in guidelines development for the management of abnormal cervical cancer screening tests","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib17","article-title":"Human Papillomaviruses","volume":"64","year":"1995"},{"key":"10.1016\/j.jasc.2020.05.002_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/cncy.21480","article-title":"Primary human papillomavirus screening for cervical cancer in the United States\u2014US Food and Drug Administration approval, clinical trials, and where we are today","volume":"122","author":"Nayar","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jasc.2017.12.001","article-title":"Primary HPV cervical cancer screening in the United States: are we ready?","volume":"7","author":"Nayar","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jasc.2018.08.005","article-title":"An advocacy victory: final USPSTF cervical cancer screening recommendations revised to include cotesting option","volume":"7","author":"Davey","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqaa074","article-title":"Contributions of liquid-based (Papanicolaou) cytology and human papillomavirus testing in cotesting for detection of cervical cancer and precancer, in the United States","author":"Kaufman","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high risk papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2020.05.002_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncy.21875","article-title":"Performance of Aptima and cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer","volume":"125","author":"Ge","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jasc.2019.06.001","article-title":"A review of the FDA-approved molecular testing platforms for human papillomavirus","volume":"8","author":"Salazar","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/LGT.0000000000000530","article-title":"A study of partial human papillomavirus genotyping in support of the 2019 ASCCP Risk-Based Management Consensus Guidelines","volume":"24","author":"Demarco","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib26","series-title":"The 2001 Bethesda System for Reporting Cervical Cytology","year":"2004"},{"key":"10.1016\/j.jasc.2020.05.002_bib27","series-title":"The Bethesda System for Reporting Cervical Cytology","year":"2015"},{"key":"10.1016\/j.jasc.2020.05.002_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0046-8177(99)90143-0","article-title":"Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection","volume":"30","author":"Ronnett","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1309\/HL0B-C7Y6-AC77-ND2U","article-title":"Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations","volume":"117","author":"Lee","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2020.05.002_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.OGX.0000070068.74408.F6","article-title":"Atypical glandular cells: new Bethesda terminology and management guidelines","volume":"58","author":"Levine","year":"2003","journal-title":"Obstetr Gynecol Surv"},{"key":"10.1016\/j.jasc.2020.05.002_bib32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.5858\/arpa.LGT200570","article-title":"The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"136","author":"Darragh","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib33","series-title":"WHO Classification of Tumours of Female Reproductive Organs","year":"2014"},{"key":"10.1016\/j.jasc.2020.05.002_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5858\/arpa.2019-0241-OA","article-title":"Relationships of p16 immunohistochemistry and other biomarkers with diagnoses of cervical abnormalities: implications for LAST terminology","volume":"144","author":"Castle","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1309\/AJCPXSVCDZ3D5MZM","article-title":"Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia","volume":"133","author":"Bergeron","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib36","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1097\/PAS.0000000000000494","article-title":"Role of the biomarker p16 in downgrading -IN 2 diagnoses and predicting higher-grade lesions","volume":"39","author":"Maniar","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/PAS.0000000000001072","article-title":"Routine use of adjunctive p16 immunohistochemistry improves diagnostic agreement of cervical biopsy interpretation: results from the CERTAIN Study","volume":"42","author":"Stoler","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ajcp\/aqw032","article-title":"Effect of lower anogenital squamous terminology recommendations on the use of p16 immunohistochemistry and the proportion of high-grade diagnoses in cervical biopsy specimens","volume":"145","author":"Thrall","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1309\/AJCP3TPHV4TRIZEK","article-title":"p16INK4a immunohistochemistry in cervical biopsy specimens: a systematic review and meta-analysis of the interobserver agreement","volume":"142","author":"Reuschenbach","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN 3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/PT3PNC1QL2F4D2VL","article-title":"The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report","volume":"127","author":"Castle","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/LGT.0000000000000322","article-title":"Evidence-based consensus recommendations for colposcopy practice for cervical cancer prevention in the United States","volume":"21","author":"Wentzensen","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","article-title":"Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study","volume":"9","author":"McCredie","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.05.002_bib44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jasc.2020.05.002_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/LGT.0000000000000046","article-title":"Squamous intraepithelial lesion in cervical tissue samples of limited adequacy and insufficient for grading as high or low grade: outcome, clinic-pathological correlation, and predictive role of p16INK4a and Ki67 biomarker staining","volume":"19","author":"Lee","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2020.05.002_bib46","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003761","article-title":"Diagnosis and management of adenocarcinoma in situ: a Society of Gynecologic Oncology evidence-based review and recommendations","volume":"135","author":"Teoh","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2020.05.002_bib47","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/00000478-200010000-00012","article-title":"Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?","volume":"24","author":"Park","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PAS.0000000000000543","article-title":"Invasive stratified mucin-producing carcinoma and stratified mucin-producing intraepithelial lesion (SMILE): 15 cases presenting a spectrum of cervical neoplasia with description of a distinctive variant of invasive adenocarcinoma","volume":"40","author":"Lastra","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00428-020-02770-3","article-title":"The evolving spectrum of endocervical adenocarcinoma in situ (AIS)","volume":"476","author":"Stolnicu","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jasc.2020.05.002_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/dc.23381","article-title":"Cytologic findings in stratified mucin-producing intraepithelial lesion of the cervix: a report of 34 cases","volume":"44","author":"Backhouse","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib51","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00404-013-2889-6","article-title":"Perinatal outcomes of pregnant women with cervical intraepithelial neoplasia","volume":"288","author":"He","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jasc.2020.05.002_bib52","author":"McMorrow"},{"key":"10.1016\/j.jasc.2020.05.002_bib53","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jasc.2020.05.002_bib54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000381","article-title":"The interpretive variability of cervical biopsies and its relationship to HPV status","volume":"205","author":"Stoler","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.humpath.2016.04.010","article-title":"Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation","volume":"55","author":"Clark","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib56","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/PGP.0b013e31827b26b1","article-title":"Interobserver agreement in the reporting of cervical biopsy specimens obtained from women screened by visual inspection with acetic acid and hybrid capture 2","volume":"32","author":"Basu","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib57","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1309\/AJCPBRK7D1YIUWFP","article-title":"The reproducibility of CIN diagnoses among different pathologists: data from histology review from a multicenter randomized study","volume":"132","author":"Dalla Palma","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1471-0528.1998.tb10054.x","article-title":"Inter- and intra-observer variation in the histologic reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system","volume":"105","author":"McCluggage","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jasc.2020.05.002_bib59","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.5858\/1999-123-1079-IVISOS","article-title":"Interobserver variability in subclassification of squamous intraepithelial lesions: results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology","volume":"123","author":"Woodhouse","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5858\/arpa.2018-0003-CP","volume":"142","author":"Crothers","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5858\/2006-130-456-PTWMHA","article-title":"Papanicolaou tests with mixed high-grade and low-grade squamous intraepithelial lesion features: distinct performance in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytopathology","volume":"130","author":"Renshaw","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cncy.20165","article-title":"Cytologic-histologic correlation","volume":"119","author":"Raab","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cncy.21991","article-title":"Cytologic-histologic correlation: where are we now, and where are we going?","volume":"126","author":"Crothers","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/arpa.2012-0115-CP","article-title":"The Tahoe Study: bias in the interpretation of Papanicolaou test results with human papillomavirus status is known","volume":"138","author":"Moriarty","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2020.05.002_bib65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/cncy.21783","article-title":"Knowledge of HPV status biases cytotechnologist\u2019s interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy","volume":"125","author":"Doxtader","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2020.05.002_bib66","first-page":"7146","article-title":"Clinical laboratory improvement amendments of 1988: final rule","volume":"57","year":"1992","journal-title":"Fed Regist"},{"key":"10.1016\/j.jasc.2020.05.002_bib67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5858\/arpa.2012-0117-CC","article-title":"General quality practices in gynecologic cytopathology: College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 3","volume":"137","author":"Tworek","year":"2013","journal-title":"Arch Pathol Lab Med"}],"updated-by":[{"DOI":"10.1016\/j.jasc.2020.09.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294520300818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T19:28:43Z","timestamp":1615922923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294520300818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213294520300818"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2020.05.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jasc.2020.09.011","asserted-by":"object"}]},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}